OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹102 Cr | ₹70 Cr | ₹54 Cr | ₹54 Cr | ₹31 Cr |
What is the latest Total Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹102 Cr |
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹31 Cr |
How is Total Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹102 Cr | 46.48 | |
| Mar2025 | ₹70 Cr | 28.21 | |
| Mar2024 | ₹54 Cr | 0.36 | |
| Mar2023 | ₹54 Cr | 74.06 | |
| Mar2022 | ₹31 Cr | - | |
Compare Total Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹236.3 Cr | -2.3% | 29.3% | -25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -2.3% |
29.3% |
-25.3% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses